Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombin inhibitors and cardiopulmonary bypass.

× No keyword cloud information.

63 in total

1. Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition.

Authors: J T Walls; J J Curtis; D Silver; T M Boley; R A Schmaltz; W Nawarawong
Journal: Ann Thorac Surg Date: 1992-05 Impact factor: 4.330

Review 2. Low-molecular-weight heparins.

Authors: J I Weitz
Journal: N Engl J Med Date: 1997-09-04 Impact factor: 91.245

Review 3. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.

Authors: M J Hursting; K L Alford; J C Becker; R L Brooks; J L Joffrion; G D Knappenberger; P W Kogan; T P Kogan; A A McKinney; R P Schwarz
Journal: Semin Thromb Hemost Date: 1997 Impact factor: 4.180

4. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

Authors: T L Bauer; G Arepally; B A Konkle; B Mestichelli; S S Shapiro; D B Cines; M Poncz; S McNulty; J Amiral; W W Hauck; R N Edie; J D Mannion
Journal: Circulation Date: 1997-03-04 Impact factor: 29.690

Review 5. Cardiopulmonary bypass in humans: bypassing unfractionated heparin.

Authors: J W Frederiksen
Journal: Ann Thorac Surg Date: 2000-10 Impact factor: 4.330

6. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.

Authors:
Journal: Lancet Date: 2002-01-26 Impact factor: 79.321

7. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.

Authors: P M Newman; R L Swanson; B H Chong
Journal: Thromb Haemost Date: 1998-08 Impact factor: 5.249

8. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans.

Authors: I Fox; A Dawson; P Loynds; J Eisner; K Findlen; E Levin; D Hanson; T Mant; J Wagner; J Maraganore
Journal: Thromb Haemost Date: 1993-02-01 Impact factor: 5.249

Review 9. Direct thrombin inhibitors.

Authors: Jeffrey I Weitz; Mark Crowther
Journal: Thromb Res Date: 2002-05-01 Impact factor: 3.944

10. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.

Authors: Andreas Koster; George Despotis; Marcus Gruendel; Thomas Fischer; Michael Praus; Herman Kuppe; Jerrold H Levy
Journal: Anesth Analg Date: 2002-07 Impact factor: 5.108